# Kesmalea Therapeutics Limited

## Details

- **Company number:** [12961631](https://find-and-update.company-information.service.gov.uk/company/12961631)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 20 Oct 2020
- **Registered office:** 2ND FLOOR, 8, BLOOMSBURY STREET, LONDON, WC1B 3SR
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ROSTOM, Raghd, Dr | director | 6 Nov 2025 |  |
| CLACKSON, Timothy Piers, Dr | director | 9 May 2025 |  |
| FINCH, Harry | director | 20 Oct 2020 |  |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Syncona Limited | ownership-of-shares-50-to-75-percent, voting-rights-50-to-75-percent | 8 Sep 2022 |  |
| Harry Finch | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 20 Oct 2020 | 8 Sep 2022 |



## Accounts

| Year ended | Net assets | Employees |
|---|---|---|
| 31 Mar 2022 | £1,400 | 0 |
| 31 Oct 2021 | £5,000 | 0 |





## Directors' other companies

- [ROSTOM, Raghd, Dr](/person/7763200) - director at [Keystrand Therapeutics Limited](/company/17426218)